To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV
Clinical trial NCT04054492 · COMPLETED
Trial details
- NCT number
- NCT04054492
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-01-25
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.